Table 1 Baseline demographics and clinical features of COVID-19 patients in each group
Demographic and clinical features | Group A (n = 50) | Group B (n = 43) | Group C (n = 43) |
|---|---|---|---|
Age, mean ± SD, years | 39.90 ± 11.34 | 38.41 ± 11.38 | 39.06 ± 12.71 |
Gender, M/F | 33/17 | 28/15 | 30/13 |
Time between first diagnosis and enrollment, median (IQR), days | 1 (0.25–2) | 1 (0–2) | 1 (1–2) |
Fever, no. (%) | 30 (60) | 24 (55.81) | 23 (53.49) |
Cough, no. (%) | 27 (54) | 24 (55.81) | 16 (37.21) |
Difficulty in breathing, no. (%) | 6 (12) | 5 (11.63) | 3 (6.98) |
Dyspnea, no. (%) | 2 (4) | 3 (6.98) | 2 (4.65) |
Sore throat, no. (%) | 14 (28) | 15 (34.88) | 18 (41.86) |
Headache, no. (%) | 11 (22) | 13 (30.23) | 14 (32.56) |
Joint pain, no. (%) | 4 (8) | 6 (13.95) | 3 (6.98) |
Fatigue, no. (%) | 8 (16) | 9 (20.93) | 5 (11.63) |
Running nose, no. (%) | 3 (6) | 3 (6.98) | 0 (0) |
Nasal congestion, no. (%) | 1 (2) | 3 (6.98) | 3 (6.98) |
Loss_Smell, no. (%) | 14 (28) | 13 (30.23) | 8 (18.6) |
Loss_Taste, no. (%) | 11 (22) | 13 (30.23) | 6 (13.95) |
Diarrhea, no. (%) | 2 (4) | 1 (2.33) | 0 (0) |
Vomiting, no. (%) | 1 (2) | 1 (2.33) | 1 (2.33) |